Obesity and type 2 diabetes are deeply interconnected. Yet, many diabetes prevention programs fail to adequately treat ...

The 2013 declaration of obesity as a chronic disease and the 2021 approval of semaglutide are associated with increased use ...

According to the Gallup National Health and Well-Being Index, 37% of U.S. adults now report obesity, down from 39.9% three ...

Twenty point six percent of patients followed a switcher trajectory within 12 months, with higher persistence seen for switchers.

UAB researchers report that the oral drug TIX100 prevented weight regain after stopping semaglutide in preclinical studies.

A new drug from California-based pharma company Amgen, which has concluded a phase II trial, shows promise as a powerful treatment for obesity. With just a once-monthly shot of 'MariTide,' ...

Obesity rates may exceed 50% globally in the coming decades, with India seeing rising childhood obesity. Experts say new ...

A blockbuster anti-obesity and diabetes drug could cost as little as $3 per month to manufacture once it goes off patent ...

Children and adolescents should be proactively evaluated and treated for obesity, according to new guidelines from the American Academy of Pediatrics around childhood obesity. The guidelines note that ...

Hardworking Tennesseans like me have tried changes to our diets and exercise to lose weight and maintain healthy lifestyles, but sometimes, those practices are not enough. 2.6 million Tennesseans – ...

Acetazolamide plus atomoxetine improved nocturnal CO2 and oxygenation in OHS. Find out more about this proof-of-concept trial ...

A coalition of Hispanic health and public policy organizations is pushing for New Mexico’s Medicaid program to broaden its coverage of weight loss drugs as treatment for obesity. The policy change, ...